Breaking News
July 17, 2018 - Women Often Unaware of Their Hospital’s Religious Affiliation
July 17, 2018 - CRISPR editing reduces repetitive behavior in mice with a form of autism
July 17, 2018 - Scientists use magnets to detect cancer
July 17, 2018 - Microfluidic chip to detect sepsis proves successful in clinical study
July 17, 2018 - Research provides better understanding of mechanisms underlying memory storage
July 17, 2018 - A Multi-Modal Approach for the Early Detection of Breast Cancer
July 17, 2018 - Mailing colorectal cancer tests to patients increases screening rates, report researchers
July 17, 2018 - Scientists find possible sources of medicinal and antimicrobial drugs
July 17, 2018 - Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer
July 17, 2018 - Efficient communication between hospitals improves patient safety and reduces mortality
July 17, 2018 - Study highlights potential of fetal gene therapy to prevent lethal neurodegenerative disease
July 17, 2018 - For Americans, in Science They Trust
July 17, 2018 - Combating HIV/AIDS | NIH MedlinePlus the Magazine
July 17, 2018 - Study shows minorities widely underrepresented in autism diagnoses
July 17, 2018 - Multigene testing replacing BRCA tests for breast cancer risk | News Center
July 17, 2018 - Pre-clinical pilot study shows promising results of ‘concussion pill’
July 17, 2018 - Researchers reduce size of tumors in mice by artificially activating the brain’s reward system
July 17, 2018 - New study documents symptoms of people before they acquire multiple sclerosis
July 17, 2018 - Researchers discover why CRISPR gene editing sometimes fails
July 17, 2018 - New finding may hold key to better understand the complexities of neurological disorders
July 17, 2018 - The Current issue of “The view from here” is concerned with Novel Targets.
July 17, 2018 - Fighting the Flu with a Universal Vaccine
July 17, 2018 - Key social reward circuit in the brain impaired in kids with autism | News Center
July 17, 2018 - Insight into causes, types and treatment of aphasia
July 16, 2018 - Quark Pharmaceuticals, Inc Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
July 16, 2018 - NSAIDs shown to have causal role in cardiovascular risk of patients with osteoarthritis
July 16, 2018 - PET scan tracer predicts success of cancer ‘vaccine’ | News Center
July 16, 2018 - Parents struggle with what to do when their child has headache, shows study
July 16, 2018 - Outrageous or overblown? HHS announces another round of ACA navigator funding cuts
July 16, 2018 - Weight loss surgery may impact individual’s risk of developing cancer, shows study
July 16, 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
July 16, 2018 - Restoring epigenetic balance reinstates memory in flies with Alzheimer’s disease symptoms
July 16, 2018 - Magnetized wire could be used to detect cancer in people | News Center
July 16, 2018 - Non-surgical management found to be feasible option for penetrating kidney trauma
July 16, 2018 - California clinic screens asylum seekers for honesty
July 16, 2018 - FDA Approves Xtandi (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
July 16, 2018 - Can nanotechnology help treat Alzheimer’s?
July 16, 2018 - Researchers identify protein essential for making stem cells | News Center
July 16, 2018 - Severe childhood infections linked with lower school achievement in adolescence
July 16, 2018 - Radiologist discusses causes, treatments of varicose veins
July 16, 2018 - Researchers develop nanostructured surface to accelerate wound healing after dental implants
July 16, 2018 - New non-invasive procedure to reposition kidney stones could benefit astronauts
July 16, 2018 - Attending Surgeon Influences Genetic Testing in Breast Cancer
July 16, 2018 - Medical doctors with addictions fear professional repercussions if they seek treatment
July 16, 2018 - 5 Questions: John Ioannidis calls for more rigorous nutrition research | News Center
July 16, 2018 - University of Illinois buys 3D-Bioplotter for regenerative biology, tissue engineering research
July 16, 2018 - Charité’s researchers integrate open-source platform into the ‘Human Brain Project’
July 16, 2018 - SUSU scientists develop rehabilitation device for people with lower limbs injuries
July 16, 2018 - Researchers find definite increase in scooter-related injuries
July 16, 2018 - Researchers solve mystery of final blood group system
July 16, 2018 - Researchers develop near-infrared fluorophores-based PDT to cure cancer with less side effects
July 16, 2018 - Traumatic brain injury biomarker could help predict patient prognosis
July 16, 2018 - Researchers to investigate role of hormones in mosquito’s ability to use human blood for egg production
July 16, 2018 - AHA: Doctor Makes Lifesaving House Call in His Own Home
July 16, 2018 - Nearsightedness – Genetics Home Reference
July 16, 2018 - Study shows biomarker panel boosts lung cancer risk assessment for smokers
July 16, 2018 - Researchers find link between bereavement during pregnancy, child’s mental health | News Center
July 16, 2018 - Legalizing same-sex marriage has meaningful effects on health care access for sexual-minority men
July 16, 2018 - New York to allow medical marijuana as substitute to opioids
July 16, 2018 - Reducing tapeworm infection could improve academic performance, reduce poverty | News Center
July 16, 2018 - Researchers describe key role of enzyme in regulating immune response against Chagas disease parasite
July 16, 2018 - Johnson & Johnson Announces Publication in The Lancet Highlighting Robust Immune Response to Janssen’s Mosaic-based Preventive Vaccine Regimen for HIV
July 16, 2018 - Do Racial and Gender Disparities Exist in Newer Glaucoma Treatments?
July 16, 2018 - Antibodies may predict transplant rejection risk
July 16, 2018 - New center sets out to stop disease before it starts | News Center
July 16, 2018 - FDA warns consumers about criminals sending fake warning letters
July 16, 2018 - Residential segregation linked with racial disparities in firearm homicide fatalities
July 16, 2018 - UW-Madison researchers develop new method to track Parkinson’s damage in the heart
July 16, 2018 - New approach to cultivate hypoallergenic tomato and strawberry varieties
July 16, 2018 - Smoking associated with delayed shinbone healing
July 16, 2018 - Sheila Dolezal, ‘team player extraordinaire,’ wins 2018 Amy J. Blue Award | News Center
July 16, 2018 - Advanced Prostate Cancer Variant More Common Than Thought
July 16, 2018 - New ways to conquer sleep apnea compete for place in bedroom
July 16, 2018 - Renowned microbe hunter Stanley Falkow dies at 84 | News Center
July 15, 2018 - FDA Slaps Stronger Warnings on Potent Class of Antibiotics, Fluoroquinolones
July 15, 2018 - Don’t let depression keep you from exercising
July 15, 2018 - Student research symposium showcases curiosity and scholarship | News Center
July 15, 2018 - Heavy smokers have increased risk of heart rhythm disorder, shows study
July 15, 2018 - Parents who had severe trauma, stresses in childhood more likely to have kids with behavioral health problems
July 15, 2018 - At colloquium, a range of views on value of predictive algorithms | News Center
TMVR Benefits Hold Firm in Post-Market Registry

TMVR Benefits Hold Firm in Post-Market Registry

image_pdfDownload PDFimage_print

Action Points

  • Transcatheter mitral valve repair (TMVR) with the MitraClip, for mitral valve regurgitation, was associated with low in-hospital mortality and high acute procedural success, according to registry data of 2,952 patients treated from 2013 to 2015.
  • Note that degenerative mitral regurgitation affects about 1% to 2% of the general population, and can lead to debilitating heart failure and poor long-term survival in certain patient subsets.

The MitraClip has performed favorably in the U.S. in the years since FDA approval, per post-market surveillance of patients who’ve had the device implanted to treat mitral regurgitation.

From the Society of Thoracic Surgery (STS)/American College of Cardiology Transcatheter Valve Therapy Registry, Paul Sorajja, MD, of Abbott Northwestern Hospital in Minneapolis, and colleagues determined that transcatheter mitral valve repair (TMVR) with the MitraClip was associated with low in-hospital mortality (2.7%) and high acute procedural success (91.8%).

Patients who had linkable Centers for Medicare and Medicaid claims data had encouraging outcomes out of the hospital as well, with mortality observed in 5.2% at 30 days and 25.8% at 1 year. By the end of the year, repeat hospitalization for heart failure had reached 20.2%, and the combination of mortality or heart failure rehospitalization 37.9%, Sorajja’s group reported in the Journal of the American College of Cardiology.

In all, 95.5% were discharged from hospital with mitral regurgitation grade 2 or lower without cardiac surgery and survived to 30 days.

“Our findings demonstrate that commercial transcatheter mitral valve repair is being performed in the United States with acute effectiveness and safety,” the authors concluded. Their study population underwent commercial therapy with the MitraClip after FDA approval in 2013, consisting mainly of those with severe symptoms, degenerative mitral regurgitation, and prohibitive surgical risk.

“These findings, which are consistent with prior reports on the effectiveness and safety of transcatheter mitral valve repair, are important observations as the treatment population expands, new hospital sites for the therapy accrue, and a number of potentially eligible patients remain untreated,” Sorajja’s group suggested.

On multivariable analysis, the predictors of 1-year mortality or heart failure rehospitalization were:

  • Increasing age: HR 1.08 per 5 years (95% CI 1.01-1.15)
  • Dialysis: HR 2.09 (95% CI 1.37-3.28)
  • Left ventricular ejection fraction: HR 0.92 per 5% (95% CI 0.88-0.95)
  • Moderate or severe lung disease: HR 1.28 (95% CI 1.05-1.58)
  • Severe tricuspid regurgitation: HR 1.89 (95% CI 1.48-2.39)
  • Residual mitral regurgitation grade 3 or 4 after the procedure: HR ~2.0 (95% CI ~1.4-2.0)

“Although these findings are interesting, they are no different from the factors associated with a worse outcome after mitral valve surgery. This affirms that patient-related factors are perhaps more important than the method by which mitral regurgitation is approached, either surgically or percutaneously,” commented Steven Bolling, MD, of University of Michigan Health System in Ann Arbor.

In an accompanying editorial, Bolling called MitraClip’s confirmed technical success and safety data the most important findings of the analysis.

“In fact, the safety and low biological impact of this left atrial catheter approach may allow practitioners to treat patients with mitral regurgitation much earlier in their disease course,” he said. “Perhaps therapeutic mitral regurgitation intervention will be possible even long before congestive heart failure, atrial fibrillation, tricuspid regurgitation, pulmonary hypertension, and other complications of mitral regurgitation occur, which may obscure any benefit of obviating the mitral regurgitation.”

The registry used by Sorajja’s group included 2,952 TMVR patients who were treated from 2013 to 2015, of which 63.2% had data linked to CMS administrative claims. Participants had a median age of 82 years and were 55.8% men; they presented with a median STS score of 6.1% for mitral repair and 9.2% for mitral replacement.

Rates of safety events were not excessive: 0.1% for device embolization; 3.9% for major or life-threatening bleeding; 0.4% for stroke, and 0.1% for MI. Conversion to open heart surgery was required by 2.7%.

Notably, mortality and heart failure hospitalization at 1 year grew more likely with increasing severity of residual mitral regurgitation after TMVR. Combined, this endpoint was reported in 35.7%, 39.2%, and 54.4% of those leaving the hospital with grade 1-or-below, grade 2, and grade 3-or-higher jets.

This led the investigators to concluded that their findings “support the rationale for achieving significant mitral regurgitation reduction, including minimizing need for future surgical therapy, with procedural expertise when possible, even though the desired therapeutic goal may be less certain when treating patients with limited or no other therapeutic options.”

Nevertheless, they admitted that the lack of a comparison arm was a limitation of their single-arm registry study. “Such controls, whether medical or surgical, are necessary to determine the magnitude (or lack thereof) of any clinical benefit of TMVR in these patients, particularly in high-risk individuals in which there may be continued adverse events despite initially successful therapy.”

COAPT and MITRA-FR are two trials that are comparing TMVR with guideline-directed medical therapy in two trials, Sorajja’s group said, pointing out that severe tricuspid regurgitation and severe lung disease — both associated with worse survival in the present study — are exclusion criteria for these trials.

Another caveat of the study is the lack of reasoning given for hospitalization or surgery after TMVR.

Bolling said that MitraClip is just one component of the triad approach to mitral valve disease — leaflet grasping, annular ring, and valve replacement — and together these three components “will certainly remain the gold standard when surgical mitral valve disease therapy inevitably gives way to transcatheter mitral valve disease therapies.”

“In the future, we will have all 3 of these gold standard mitral tools in our transcatheter toolbox. MitraClip will probably remain a crucial tool, but perhaps more importantly we will look at the device experience as having been a gateway to the future of catheter-based mitral valve disease therapy,” he predicted.

The study was supported by Abbott Vascular.

Sorajja disclosed relevant relationships with Abbott Vascular, Medtronic, Boston Scientific, and Integer.

Bolling disclosed a relevant relationships with Abbott.

2017-10-30T14:00:00-0400

Tagged with:

About author

Related Articles